“…Disease prognosis can be assessed by a wide range of risk stratification and staging systems, such as MACIS (distant metastasis, age, completeness of primary tumor resection, local invasion, tumor size), AMES (age, distant metastasis, tumor extent, tumor size), AGES (age, grade, tumor extent, tumor size), and TNM ® (tumor, node metastasis, distant metastasis) 3 . The last system 2/9 THYROID DISEASES Impact of TNM® 8 th edition on thyroid cancer retrospective staging was developed in France by Pierre Denoix in 1940, and is currently the most used globally for the treatment, study, and research of malignant neoplasms.…”